•  
  •  
  •  
  •  

2025-09-02 01:25:12

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp dispatches 5.54 lakh Motorcycles and Scooters in August 2025
  • InfoBeans Technologies Ltd wins Asia's Best Employer Brand Award from World HRD Congress
  • Websol Energy System Ltd approves expansion of manufacturing capacity
  • CEAT acquires Michelin Group's CAMSO Construction Compact Line Business
  • BCML collaborates with CIPET Ahmedabad to bring 'Bioyug on Wheels'

Keywords Selected:  INE03QK01018

Stock Report

  • Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide Facility at Hyderabad, India
  • Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation
  • Cohance Lifesciences Appoints Yann D'Herve as CEO of CDMO Business, Effective August 1, 2025
  • Cohance Lifesciences Ltd to sell CR Bio assets to Chromo Laboratories India Pvt Ltd
  • Suven Pharmaceuticals Ltd is now Cohance Lifesciences Ltd
  • Suven Pharmaceuticals announces May 1, 2025 as Effective Date for Amalgamation of Cohance Lifesciences
  • Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
  • Suven to acquire controlling stake in NJ Bio, Inc., an ADC specialist player
  • Suven Pharmaceuticals names Mr. Vivek Sharma as Executive Chairman
  • Suven Pharmaceuticals Ltd gets Form 483 from USFDA for inspection at Casper Pharma Pvt Ltd
  • Suven to acquire a majority stake in an oligonucleotide focused CDMO player, Sapala Organics
  • Suven announces merger of Cohance Lifesciences
  • Suven Pharmaceuticals Ltd's API and Forumulations facilities complete USFDA inspection successfully
  • Advent International announces the completion of the acquisition of Suven Pharma
  • Berhyanda Ltd gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals Ltd
  • Advent announces Open offer for Suven Pharma at Rs. 495 per share
  • Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family
  • Casper Pharma completed USFDA pre-approval inspection
  • Suven Pharmaceuticals Limited declares 2nd interim dividend of Rs. 1
  • Suven Pharmaceuticals approves acquisition of Casper Pharma Pvt Ltd
  • Suven Pharma declares interim dividend of Rs. 1, special dividend of Rs. 2
  • Suven Pharma arm divests stake in Rising Pharma Holdings, Inc., USA

Latest Post

  • Hero MotoCorp dispatches 5.54 lakh Motorcycles and Scooters in August 2025
  • InfoBeans Technologies Ltd wins Asia's Best Employer Brand Award from World HRD Congress
  • Websol Energy System Ltd approves expansion of manufacturing capacity
  • CEAT acquires Michelin Group's CAMSO Construction Compact Line Business
  • BCML collaborates with CIPET Ahmedabad to bring 'Bioyug on Wheels'


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024